OxyFile #531

Medizone International announces terminated CEO, Joseph
S. Latino, resigns from the company's board of directors. 


Contact: Bill Roberts (513) 469-0202 

Salt Lake City, Utah - July 9, 1997, - Medizone International, 
Inc. ("Medizone") (OTC.BB: MZEI.U) announced today that Joseph S. 
Latino, Ph.D. has resigned from the company's board of directors 
effective immediately. 

Dr. Joseph S. Latino was terminated as Medizone's president, chief 
executive officer and chairman by the company's board on May 14,
1997, but in accordance with the corporation's by-laws, he 
remained a member of the medizone board of directors. Replacing 
Latino as president and full time chief executive officer is 
Milton G. Adair (64) who brings over 30 years experience in the 
biomedical field. Prior to joining Medizone, Adair was president 
and chief executive officer of Biomune Systems (NASDAQ: BIME), and 
international company specializing in nutritional aids products. 
He held this position since January 1996. From September 1991 to 
January 1996, Adair was president and chief executive officer of 
Gull Laboratories (AMEX:GUL), an international diagnostic company 
with a primary focus in the infectious disease market. Adair had 
also served as president and chief executive officer of Mountain 
Medical Equipment Company and Orbit Medical Systems (a venture 
company in immunochemistry) as well as serving as an FDA liason 
officer to ensure compliance on new drug applications and 
labeling. 

Medizone is developing the utilization of thin film technology in 
the application of ozone for the decontamination of blood and 
blood products as well as for therapeutic treatment of certain 
diseases caused by lipid enveloped viruses, including Aquired 
Immunodeficiency Syndrome (Aids), Hepatitis B, Herpes and Epstein 
Barr. Medizone is a development state company.